Title : Arsenic trioxide overcomes rapamycin-induced feedback activation of AKT and ERK signaling to enhance the anti-tumor effects in breast cancer.

Pub. Date : 2013

PMID : 24392034






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Arsenic trioxide overcomes rapamycin-induced feedback activation of AKT and ERK signaling to enhance the anti-tumor effects in breast cancer. Arsenic Trioxide AKT serine/threonine kinase 1 Homo sapiens
2 Previously, we published that arsenic trioxide (ATO) inhibits AKT activity and in some cases, decreases AKT protein expression. Arsenic Trioxide AKT serine/threonine kinase 1 Homo sapiens
3 Previously, we published that arsenic trioxide (ATO) inhibits AKT activity and in some cases, decreases AKT protein expression. Arsenic Trioxide AKT serine/threonine kinase 1 Homo sapiens
4 Previously, we published that arsenic trioxide (ATO) inhibits AKT activity and in some cases, decreases AKT protein expression. Arsenic Trioxide AKT serine/threonine kinase 1 Homo sapiens
5 Previously, we published that arsenic trioxide (ATO) inhibits AKT activity and in some cases, decreases AKT protein expression. Arsenic Trioxide AKT serine/threonine kinase 1 Homo sapiens
6 Therefore, we propose that combining ATO and rapamycin may circumvent the AKT feedback loop and increase the anti-tumor effects. Arsenic Trioxide AKT serine/threonine kinase 1 Homo sapiens